Sep 10 : An advance diabetic care and research center to come up at Bangalore at an estimated cost of Rs 6 crores as announced by the Medical Education Minister Dr V. S Acharya, while launching of a Super Speciality centre at Yenyoppa Hospital in Mangalore.
Yenyoppa Group provides services in various social sectors and health care with world class facilities.
He said that Central government has already given its approval, with a sub center at Mangalore, Dharwad and Shimoga.
He said that government has liberalized its policy regarding setting up of new medical institutions so that the state will have more good institutes which offer courses from diploma to super speciality.
He also emphasised that poor in this country should not be left behind and such facilities should reaches to the entire needy household.
Hospitals in private sector should try to provide advanced medical facility to the poor with the help of organisations, he said and added; ‘‘majority in our society are deprived of services of advanced medical technology.’’
‘‘Quality of our medical education especially in the field of nursing should match international standard since large number of students opt developed countries after their education,’’ he added.
Quoting a survey report, Acharya said that cardiovascular disorders, diabetics, cancer, HIV and other related diseases and accidents were the major challenges which doctors would have to face in future. ‘‘Doctors and Institutions should prepare to face the challenges ahead,’’ he added.
Dr Acharya appreciated the over all development of medical sciences in the state with the help of private entrepreneurs and various trusts and organisations.
This advance Diabetic centre will help to address the patient in India where it is increased three fold in last twenty years. Also it has been estimated that India will have 20% of Diabetic patient in the whole world by 2010. In Diabetic patient further complication of blindness, kidney failure, heart attack, gangrene are also associated.
This explosion has also drawn the concern of the World Health Organization (WHO) and the International Diabetes federation (IDF).